Pomanda estimates the enterprise value of STINGRAY BIO LIMITED at £66.6k based on a Turnover of £68.3k and 0.97x industry multiple (adjusted for size and gross margin).
stingray bio limitedEstimated Valuation
£0
Pomanda estimates the enterprise value of STINGRAY BIO LIMITED at £0 based on an EBITDA of £-88k and a 3.84x industry multiple (adjusted for size and gross margin).
stingray bio limitedEstimated Valuation
£37.3k
Pomanda estimates the enterprise value of STINGRAY BIO LIMITED at £37.3k based on Net Assets of £20.9k and 1.79x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Stingray Bio LimitedOverview
Stingray Bio Limited is a live company located in cambridge, CB22 5HX with a Companies House number of 13065548. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in December 2020, it's largest shareholder is
georgios giamas
with a 45% stake. Stingray Bio Limited is a young,
micro sized company, Pomanda has estimated its turnover at
£68.3k with
unknown
growth in recent years.
Pomanda's financial health check has awarded Stingray Bio Limited a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 6 areas for improvement. Company Health Check FAQs
Health Rating1.5out of 5
1 Strong
2 Regular
6 Weak
Size
annual sales of £68.3k, make it smaller than the average company (£4.5m)
£68.3k - Stingray Bio Limited
£4.5m - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- - Stingray Bio Limited
- - Industry AVG
Production
with a gross margin of 25.6%, this company has a higher cost of product (54%)
25.6% - Stingray Bio Limited
54% - Industry AVG
Profitability
an operating margin of -128.8% make it less profitable than the average company (-4.4%)
-128.8% - Stingray Bio Limited
-4.4% - Industry AVG
Employees
with 1 employees, this is below the industry average (54)
1 - Stingray Bio Limited
54 - Industry AVG
Pay Structure
on an average salary of £83.2k, the company has an equivalent pay structure (£83.2k)
£83.2k - Stingray Bio Limited
£83.2k - Industry AVG
Efficiency
resulting in sales per employee of £68.3k, this is less efficient (£131.7k)
£68.3k - Stingray Bio Limited
£131.7k - Industry AVG
Debtor Days
it gets paid by customers after 143 days, this is later than average (56 days)
143 days - Stingray Bio Limited
56 days - Industry AVG
Creditor Days
its suppliers are paid after 184 days, this is slower than average (60 days)
184 days - Stingray Bio Limited
60 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Stingray Bio Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Stingray Bio Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 56.8%, this is a similar level of debt than the average (52.5%)
56.8% - Stingray Bio Limited
52.5% - Industry AVG
STINGRAY BIO LIMITED financials
EXPORT
Stingray Bio Limited's latest turnover from December 2023 is estimated at £68.3 thousand and the company has net assets of £20.9 thousand. According to their latest financial statements, we estimate that Stingray Bio Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Dec 2023
Dec 2022
Dec 2021
Turnover
68,348
278,043
419,997
Other Income Or Grants
Cost Of Sales
50,821
200,951
306,610
Gross Profit
17,527
77,092
113,387
Admin Expenses
105,529
126,192
-81,619
Operating Profit
-88,002
-49,100
195,006
Interest Payable
Interest Receivable
Pre-Tax Profit
-88,002
-49,100
195,006
Tax
-37,051
Profit After Tax
-88,002
-49,100
157,955
Dividends Paid
Retained Profit
-88,002
-49,100
157,955
Employee Costs
83,156
78,449
156,281
Number Of Employees
1
1
2
EBITDA*
-88,002
-49,100
195,006
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023
Dec 2022
Dec 2021
Tangible Assets
840
1,650
Intangible Assets
Investments & Other
260
260
260
Debtors (Due After 1 year)
Total Fixed Assets
1,100
1,910
260
Stock & work in progress
Trade Debtors
26,929
128,341
187,350
Group Debtors
Misc Debtors
20,250
Cash
misc current assets
total current assets
47,179
128,341
187,350
total assets
48,279
130,251
187,610
Bank overdraft
Bank loan
Trade Creditors
25,676
19,646
28,655
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities
total current liabilities
25,676
19,646
28,655
loans
hp & lease commitments
Accruals and Deferred Income
1,750
1,750
1,000
other liabilities
provisions
total long term liabilities
1,750
1,750
1,000
total liabilities
27,426
21,396
29,655
net assets
20,853
108,855
157,955
total shareholders funds
20,853
108,855
157,955
Dec 2023
Dec 2022
Dec 2021
Operating Activities
Operating Profit
-88,002
-49,100
195,006
Depreciation
Amortisation
Tax
-37,051
Stock
Debtors
-81,162
-59,009
187,350
Creditors
6,030
-9,009
28,655
Accruals and Deferred Income
750
1,000
Deferred Taxes & Provisions
Cash flow from operations
-810
1,650
260
Investing Activities
capital expenditure
810
-1,650
Change in Investments
260
cash flow from investments
810
-1,650
-260
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
interest
cash flow from financing
cash and cash equivalents
cash
overdraft
change in cash
stingray bio limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for stingray bio limited. Get real-time insights into stingray bio limited's credit score, group structure and payment trends.
Perform a competitor analysis for stingray bio limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other micro companies, companies in CB22 area or any other competitors across 12 key performance metrics.
stingray bio limited Ownership
STINGRAY BIO LIMITED group structure
Stingray Bio Limited has no subsidiary companies.
Ultimate parent company
STINGRAY BIO LIMITED
13065548
STINGRAY BIO LIMITED Shareholders
The largest shareholders in Stingray Bio Limited include Georgios Giamas and O2H Nominees Limited (On Behalf Of O2H Ventures Limited).
georgios giamas
44.99%
o2h nominees limited (on behalf of o2h ventures limited)
36.63%
university of sussex
12.76%
john spencer
5.62%
stingray bio limited directors
Stingray Bio Limited currently has 2 directors.
The longest serving directors include
Mr Georgios Giamas (Dec 2020) and
Mr Sunil Shah (Apr 2021).
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to stingray bio limited.
stingray bio limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for STINGRAY BIO LIMITED. This can take several minutes, an email will notify you when this has completed.
stingray bio limitedCompanies House Filings - See Documents
